mRNA Platform Innovations Beyond Vaccines
Messenger RNA technology moved into global focus during the COVID-19 vaccine rollout, but the platform’s scientific potential extends well beyond infectious disease prevention. Biotechnology companies, academic labs, and investors are increasingly investigating mRNA as a programmable therapeutic modality capable of addressing oncology, rare diseases, and regenerative medicine. The underlying appeal lies in the platform’s flexibility. … Read more